Your browser doesn't support javascript.
loading
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.
Halatoko, Wemboo Afiwa; Konu, Yao Rodion; Gbeasor-Komlanvi, Fifonsi Adjidossi; Sadio, Arnold Junior; Tchankoni, Martin Kouame; Komlanvi, Koffi Segbeaya; Salou, Mounerou; Dorkenoo, Ameyo Monique; Maman, Issaka; Agbobli, Amétépé; Wateba, Majesté Ihou; Adjoh, Komi Séraphin; Goeh-Akue, Edem; Kao, Yem-Bla; Kpeto, Innocent; Pana, Paul; Kinde-Sossou, Rebecca; Tamekloe, Agbeko; Nayo-Apétsianyi, Josée; Assane, Simon-Pierre Hamadi; Prine-David, Mireille; Awoussi, Sossinou Marcel; Djibril, Mohaman; Mijiyawa, Moustafa; Dagnra, Anoumou Claver; Ekouevi, Didier Koumavi.
Afiliação
  • Halatoko WA; Institut National d'Hygiène (INH), Lomé, Togo.
  • Konu YR; Département de Santé Publique, Université de Lomé, Lomé, Togo.
  • Gbeasor-Komlanvi FA; Centre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Lomé, Togo.
  • Sadio AJ; Département de Santé Publique, Université de Lomé, Lomé, Togo.
  • Tchankoni MK; Centre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Lomé, Togo.
  • Komlanvi KS; Département de Santé Publique, Université de Lomé, Lomé, Togo.
  • Salou M; Centre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Lomé, Togo.
  • Dorkenoo AM; Centre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Lomé, Togo.
  • Maman I; Centre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP), Lomé, Togo.
  • Agbobli A; Laboratoire de Biologie Moléculaire et d'Immunologie (BIOLIM), Université de Lomé, Lomé Togo.
  • Wateba MI; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
  • Adjoh KS; Conseil Scientifique pour la Riposte contre la pandémie de Covid-19, Lomé, Togo.
  • Goeh-Akue E; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
  • Kao YB; Ministère de la Santé et de l'Hygiène Publique, Lomé, Togo.
  • Kpeto I; Institut National d'Hygiène (INH), Lomé, Togo.
  • Pana P; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
  • Kinde-Sossou R; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
  • Tamekloe A; Conseil Scientifique pour la Riposte contre la pandémie de Covid-19, Lomé, Togo.
  • Nayo-Apétsianyi J; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
  • Assane SH; Conseil Scientifique pour la Riposte contre la pandémie de Covid-19, Lomé, Togo.
  • Prine-David M; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
  • Awoussi SM; Conseil Scientifique pour la Riposte contre la pandémie de Covid-19, Lomé, Togo.
  • Djibril M; Conseil Scientifique pour la Riposte contre la pandémie de Covid-19, Lomé, Togo.
  • Mijiyawa M; Conseil Scientifique pour la Riposte contre la pandémie de Covid-19, Lomé, Togo.
  • Dagnra AC; Conseil Scientifique pour la Riposte contre la pandémie de Covid-19, Lomé, Togo.
  • Ekouevi DK; Ministère de la Santé et de l'Hygiène Publique, Lomé, Togo.
PLoS One ; 15(11): e0242124, 2020.
Article em En | MEDLINE | ID: mdl-33166369
ABSTRACT

BACKGROUND:

In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new coronavirus in the country.

OBJECTIVE:

This survey aimed to estimate the prevalence of SARS-CoV-2 in high-risk populations in Lomé. MATERIALS AND

METHODS:

From April 23, 2020, to May 8, 2020, we recruited a sample of participants from five sectors health care, air transport, police, road transport and informal. We collected oropharyngeal swabs for direct detection through real-time reverse transcription polymerase chain reaction (rRT-PCR) and blood for antibody detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests.

RESULTS:

A total of 955 participants with a median age of 36 (IQR 32-43) were included, and 71.6% (n = 684) were men. Approximately 22.1% (n = 212) were from the air transport sector, 20.5% (n = 196) were from the police sector, and 38.7% (n = 370) were from the health sector. Seven participants (0.7%, 95% CI 0.3-1.6%) had a positive rRT-PCR test result at the time of recruitment, and nine (0.9%, 95% CI 0.4-1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n = 15), 95% CI 0.9-2.6%.

CONCLUSION:

The prevalence of SARS-CoV-2 infection among high-risk populations in Lomé was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus Idioma: En Ano de publicação: 2020 Tipo de documento: Article